369 related articles for article (PubMed ID: 24692538)
21. The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells.
Schaefer S; Svenstrup TH; Guerra B
PLoS One; 2017; 12(5):e0177706. PubMed ID: 28542269
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70.
Chakraborty PK; Mustafi SB; Ganguly S; Chatterjee M; Raha S
Cancer Sci; 2008 Jun; 99(6):1109-16. PubMed ID: 18429957
[TBL] [Abstract][Full Text] [Related]
23. Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function.
Li Y; Zhang T; Schwartz SJ; Sun D
Nutr Cancer; 2011; 63(7):1151-9. PubMed ID: 21875325
[TBL] [Abstract][Full Text] [Related]
24. Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy.
Rodrigues LM; Chung YL; Al Saffar NM; Sharp SY; Jackson LE; Banerji U; Stubbs M; Leach MO; Griffiths JR; Workman P
BMC Res Notes; 2012 May; 5():250. PubMed ID: 22621282
[TBL] [Abstract][Full Text] [Related]
25. Identification of mixed lineage leukemia 1(MLL1) protein as a coactivator of heat shock factor 1(HSF1) protein in response to heat shock protein 90 (HSP90) inhibition.
Chen Y; Chen J; Yu J; Yang G; Temple E; Harbinski F; Gao H; Wilson C; Pagliarini R; Zhou W
J Biol Chem; 2014 Jul; 289(27):18914-27. PubMed ID: 24831003
[TBL] [Abstract][Full Text] [Related]
26. Insights from yeast into whether the inhibition of heat shock transcription factor (Hsf1) by rapamycin can prevent the Hsf1 activation that results from treatment with an Hsp90 inhibitor.
Millson SH; Piper PW
Oncotarget; 2014 Jul; 5(13):5054-64. PubMed ID: 24970820
[TBL] [Abstract][Full Text] [Related]
27. Targeting HSF1 sensitizes cancer cells to HSP90 inhibition.
Chen Y; Chen J; Loo A; Jaeger S; Bagdasarian L; Yu J; Chung F; Korn J; Ruddy D; Guo R; McLaughlin ME; Feng F; Zhu P; Stegmeier F; Pagliarini R; Porter D; Zhou W
Oncotarget; 2013 Jun; 4(6):816-29. PubMed ID: 23615731
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation.
Krishnamoorthy GP; Guida T; Alfano L; Avilla E; Santoro M; Carlomagno F; Melillo RM
J Biol Chem; 2013 Jun; 288(24):17481-94. PubMed ID: 23629654
[TBL] [Abstract][Full Text] [Related]
29. 17-Allylamino-17-demethoxygeldanamycin and ritonavir inhibit renal cancer growth by inhibiting the expression of heat shock factor-1.
Sato A; Asano T; Ito K; Asano T
Int J Oncol; 2012 Jul; 41(1):46-52. PubMed ID: 22470109
[TBL] [Abstract][Full Text] [Related]
30. Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma.
Francis LK; Alsayed Y; Leleu X; Jia X; Singha UK; Anderson J; Timm M; Ngo H; Lu G; Huston A; Ehrlich LA; Dimmock E; Lentzsch S; Hideshima T; Roodman GD; Anderson KC; Ghobrial IM
Clin Cancer Res; 2006 Nov; 12(22):6826-35. PubMed ID: 17121904
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
[TBL] [Abstract][Full Text] [Related]
32. Heat shock protein 90 (HSP90) inhibitors activate the heat shock factor 1 (HSF1) stress response pathway and improve glucose regulation in diabetic mice.
Lee JH; Gao J; Kosinski PA; Elliman SJ; Hughes TE; Gromada J; Kemp DM
Biochem Biophys Res Commun; 2013 Jan; 430(3):1109-13. PubMed ID: 23261432
[TBL] [Abstract][Full Text] [Related]
33. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
[TBL] [Abstract][Full Text] [Related]
34. Induction of heat shock proteins by hyperthermia and noise overstimulation in hsf1 -/- mice.
Gong TW; Fairfield DA; Fullarton L; Dolan DF; Altschuler RA; Kohrman DC; Lomax MI
J Assoc Res Otolaryngol; 2012 Feb; 13(1):29-37. PubMed ID: 21932106
[TBL] [Abstract][Full Text] [Related]
35. P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.
McCollum AK; TenEyck CJ; Stensgard B; Morlan BW; Ballman KV; Jenkins RB; Toft DO; Erlichman C
Cancer Res; 2008 Sep; 68(18):7419-27. PubMed ID: 18794130
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Heat Shock Protein 90 Prevents HIV Rebound.
Joshi P; Maidji E; Stoddart CA
J Biol Chem; 2016 May; 291(19):10332-46. PubMed ID: 26957545
[TBL] [Abstract][Full Text] [Related]
37. Mammalian heat shock factor 1 is essential for oocyte meiosis and directly regulates Hsp90alpha expression.
Metchat A; Akerfelt M; Bierkamp C; Delsinne V; Sistonen L; Alexandre H; Christians ES
J Biol Chem; 2009 Apr; 284(14):9521-8. PubMed ID: 19158073
[TBL] [Abstract][Full Text] [Related]
38. Monitoring the induction of heat shock factor 1/heat shock protein 70 expression following 17-allylamino-demethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging.
Doubrovin M; Che JT; Serganova I; Moroz E; Solit DB; Ageyeva L; Kochetkova T; Pillarsetti N; Finn R; Rosen N; Blasberg RG
Mol Imaging; 2012 Feb; 11(1):67-76. PubMed ID: 22418029
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone.
Yano A; Tsutsumi S; Soga S; Lee MJ; Trepel J; Osada H; Neckers L
Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15541-6. PubMed ID: 18840695
[TBL] [Abstract][Full Text] [Related]
40. Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
Holmes JL; Sharp SY; Hobbs S; Workman P
Cancer Res; 2008 Feb; 68(4):1188-97. PubMed ID: 18281495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
